These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8258199)

  • 1. Biliary elimination and pharmacokinetics of vinorelbine in micropigs.
    Levêque D; Merle-Melet M; Bresler L; Didelot JP; Aymard JP; Wihlm J; Jehl F
    Cancer Chemother Pharmacol; 1993; 32(6):487-90. PubMed ID: 8258199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic profile of vinorelbine, a new semi-synthetic vinca alkaloid, determined by high-performance liquid chromatography.
    Levêque D; Jehl F; Quoix E; Monteil H
    Xenobiotica; 1993 Nov; 23(11):1325-33. PubMed ID: 8310715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of rifampin on the pharmacokinetics of vinorelbine in the micropig.
    Leveque D; Wisniewski S; Renault C; Peter JD; Le Corre P; Monteil H; Jehl F
    Anticancer Res; 2003; 23(3B):2741-4. PubMed ID: 12894568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography.
    van Tellingen O; Kuijpers AV; Beijnen JH; Nooijen WJ; Bult A
    Invest New Drugs; 1993; 11(2-3):141-50. PubMed ID: 8262726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography.
    Jehl F; Quoix E; Leveque D; Pauli G; Breillout F; Krikorian A; Monteil H
    Cancer Res; 1991 Apr; 51(8):2073-6. PubMed ID: 1849042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary distribution of vinorelbine in patients with non-small-cell lung cancer.
    Levêque D; Quoix E; Dumont P; Massard G; Hentz JG; Charloux A; Jehl F
    Cancer Chemother Pharmacol; 1993; 33(2):176-8. PubMed ID: 8261579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a new anticancer drug, navelbine, in patients. Comparative study of radioimmunologic and radioactive determination methods.
    Boré P; Rahmani R; van Cantfort J; Focan C; Cano JP
    Cancer Chemother Pharmacol; 1989; 23(4):247-51. PubMed ID: 2924381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and biliary elimination of temafloxacin in pigs.
    Jehl F; Bresler L; Koechlin C; Merle-Melet M; Didelot JP; Hazebroucq J
    J Antimicrob Chemother; 1992 Aug; 30(2):189-96. PubMed ID: 1328135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of [3H]navelbine in patients: comparative pharmacokinetics using radioactive and radioimmunologic determination methods.
    Rahmani R; Zhou XJ; Boré P; Van Cantfort J; Focan C; Cano JP
    Anticancer Drugs; 1991 Aug; 2(4):405-10. PubMed ID: 1797198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice.
    Tsuruo T; Inaba M; Tashiro T; Yamori T; Ohnishi Y; Ashizawa T; Sakai T; Kobayashi S; Gomi K
    Anticancer Drugs; 1994 Dec; 5(6):634-40. PubMed ID: 7888700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of navelbine after oral administration in the dog and the monkey.
    Zhou XJ; Landi H; Breillout F; Rahmani R
    Anticancer Drugs; 1993 Aug; 4(4):511-5. PubMed ID: 8400355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of vinorelbine alone and combined with cisplatin.
    Levêque D; Jehl F; Quoix E; Breillout F
    J Clin Pharmacol; 1992 Dec; 32(12):1096-8. PubMed ID: 1336784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical pharmacokinetics of vinorelbine (Navelbine).
    Wargin WA; Lucas VS
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of vinorelbine.
    Levêque D; Jehl F
    Clin Pharmacokinet; 1996 Sep; 31(3):184-97. PubMed ID: 8877249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of vinorelbine in man.
    Marquet P; Lachatre G; Debord J; Eichler B; Bonnaud F; Nicot G
    Eur J Clin Pharmacol; 1992; 42(5):545-7. PubMed ID: 1607002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical pharmacokinetics of vinca alkaloids].
    Rahmani R; Samak R; Bore P; Cano JP
    Bull Cancer; 1988; 75(2):195-200. PubMed ID: 3359064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral versus intravenous vinorelbine: clinical safety profile.
    Gebbia V; Puozzo C
    Expert Opin Drug Saf; 2005 Sep; 4(5):915-28. PubMed ID: 16111453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
    Gomi K; Ohno H; Nomura K; Okabe M; Kobayashi K; Niitani H
    Jpn J Cancer Res; 1992 May; 83(5):532-9. PubMed ID: 1618703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.